115 related articles for article (PubMed ID: 18243512)
1. Editorial comment on: chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction.
Usta MF
Eur Urol; 2008 Jun; 53(6):1288-9. PubMed ID: 18243512
[No Abstract] [Full Text] [Related]
2. Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction.
Park K; Ryu KS; Li WJ; Kim SW; Paick JS
Eur Urol; 2008 Jun; 53(6):1282-8. PubMed ID: 18243503
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of vardenafil (a PDE-5 Inhibitor) on corpus cavernosal smooth muscle relaxation in diabetic rabbits.
Lau DH; Mumtaz FH; Mikhailidis DP; Thompson CS
Urol Int; 2009; 82(1):101-7. PubMed ID: 19172107
[TBL] [Abstract][Full Text] [Related]
4. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.
Ferrini MG; Kovanecz I; Sanchez S; Vernet D; Davila HH; Rajfer J; Gonzalez-Cadavid NF
Biol Reprod; 2007 May; 76(5):915-23. PubMed ID: 17287493
[TBL] [Abstract][Full Text] [Related]
5. Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats.
De Young LX; Domes T; Lim K; Carson J; Brock GB
Eur Urol; 2008 Jul; 54(1):213-20. PubMed ID: 18342431
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluations of sildenafil analogues for treatment of erectile dysfunction.
Flores Toque HA; Priviero FB; Teixeira CE; Perissutti E; Fiorino F; Severino B; Frecentese F; Lorenzetti R; Baracat JS; Santagada V; Caliendo G; Antunes E; De Nucci G
J Med Chem; 2008 May; 51(9):2807-15. PubMed ID: 18393409
[TBL] [Abstract][Full Text] [Related]
7. Effect of sildenafil citrate on penile weight and physiology of cavernous smooth muscle in a post-radical prostatectomy model of erectile dysfunction in rats.
Özden E; Öztürk B; Koşan M; Tezel GG; Aki FT; Gür S; Ergen A; Özen H
Urology; 2011 Mar; 77(3):761.e1-7. PubMed ID: 21256544
[TBL] [Abstract][Full Text] [Related]
8. Effects of the specific phosphodiesterase inhibitors on alloxan-induced diabetic rabbit cavernous tissue in vitro.
Utkan T; Yildirim MK; Yildirim S; Sarioglu Y
Int J Impot Res; 2001 Feb; 13(1):24-30. PubMed ID: 11313837
[TBL] [Abstract][Full Text] [Related]
9. Restoring erectile function by antioxidant therapy in diabetic rats.
Hirata H; Kawamoto K; Kikuno N; Kawakami T; Kawakami K; Saini S; Yamamura S; Dahiya R
J Urol; 2009 Nov; 182(5):2518-25. PubMed ID: 19765757
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms that could contribute to prolonged effectiveness of PDE5 inhibitors to improve erectile function.
Francis SH; Morris GZ; Corbin JD
Int J Impot Res; 2008; 20(4):333-42. PubMed ID: 18418391
[TBL] [Abstract][Full Text] [Related]
11. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation.
Lysiak JJ; Yang SK; Klausner AP; Son H; Tuttle JB; Steers WD
J Urol; 2008 Feb; 179(2):779-85. PubMed ID: 18082193
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of gene expression profile in the corpus cavernosum of hypercholesterolemic rats after chronic treatment with PDE5 inhibitor.
Jung HG; Shin JH; Kim KW; Yu JY; Kang KK; Ahn BO; Kwon JW; Yoo M
Life Sci; 2007 Jan; 80(7):699-708. PubMed ID: 17137605
[TBL] [Abstract][Full Text] [Related]
13. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.
Burnett AL; Strong TD; Trock BJ; Jin L; Bivalacqua TJ; Musicki B
J Urol; 2009 Jan; 181(1):245-51. PubMed ID: 19013603
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
[TBL] [Abstract][Full Text] [Related]
15. Penile rehabilitation following radical prostatectomy.
Mulhall JP
Curr Opin Urol; 2008 Nov; 18(6):613-20. PubMed ID: 18832948
[TBL] [Abstract][Full Text] [Related]
16. Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats.
Lee SK; Kim Y; Kim TK; Im GJ; Lee BY; Kim DH; Jin C; Yoo HH
J Pharm Biomed Anal; 2009 Feb; 49(2):513-8. PubMed ID: 19095395
[TBL] [Abstract][Full Text] [Related]
17. [Phosphodiesterase 5 inhibition in erectile dysfunction. Long-term administration without therapeutic advantage].
MMW Fortschr Med; 2009 Jan; 151(1-2):50-1. PubMed ID: 19227645
[No Abstract] [Full Text] [Related]
18. Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy.
Hirschberg K; Radovits T; Loganathan S; Entz L; Beller CJ; Gross ML; Sandner P; Karck M; Szabó G
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1508-14. PubMed ID: 19464472
[TBL] [Abstract][Full Text] [Related]
19. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
20. Rehabilitation of erectile function following radical prostatectomy.
McCullough AR
Asian J Androl; 2008 Jan; 10(1):61-74. PubMed ID: 18087645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
